Is a complete SHE/300558 research report available?

Question

Accepted Answer

No complete published report is available for she/300558 (SHE/300558) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Volume
Market cap	24.4B
Revenue (ttm)	3.7B
Net income (ttm)	441.2M
EPS (ttm)	CN¥1.05
Shares out	420.7M
P/E (trailing)	55.1x
P/E (forward)	31.0x
Dividend	CN¥0.15 (0.26%)

Metric	Value
Country	China
Country code	CN
Employees	1,785
Employees Change	89%
Employees Change Percent	5.25
Enterprise value	CNY 26.5B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	34.29
Industry PE Fwd	20.25
Isin	CNE100002DD9
Last refreshed	2026-07-30
Market cap	CNY 24.4B
Price	CNY 56.81
Price currency	CNY
Rev Per Employee	2,090,543.1x
Sector	Healthcare
Sector PE	39.23
Sector PE Fwd	22.22
Sic	2834
Symbol	she/300558
Website	https://www.bettapharma.com

Metric	Value
Earnings Yield	1.81%
EV Earnings	60.14x
EV/EBIT	43.27x
EV/EBITDA	21.95x
EV/FCF	261.21x
EV/Sales	7.11x
FCF yield	0.42%
Forward P/E	31.03x
P/B ratio	3.56x
P/E ratio	55.15x
P/S ratio	6.54x
PE Ratio10 Y	88.32x
PE Ratio3 Y	61.11x
PE Ratio5 Y	81.79x

Metric	Value
EBIT Margin	16.43%
EBITDA Margin	32.32%
FCF margin	2.72%
Gross margin	78.98%
Gross Profit	CNY 2.9B
Gross Profit Growth	18.27%
Gross Profit Growth Q	10.27%
Gross Profit Growth3 Y	12.92%
Gross Profit Growth5 Y	11.51%
Net Income	CNY 441.2M
Net Income Growth	9.06%
Net Income Growth Q	135.71%
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Net Income Growth3 Y	57.4%
Net Income Growth5 Y	-6.69%
Pretax Margin	15.37%
Profit Margin	11.82%
Profit Per Employee	CNY 247,147
Profitable Quarters	CNY 1
Profitable Years	15
ROA	3.87
Roa5y	2.86
ROCE	6.81
ROE	6.75
Roe5y	5.86
ROIC	5.14
Roic5y	6.2

Metric	Value
Cagr1y	-9.21%
Cagr3y	0.91%
Cagr5y	-7.48%
Div CAGR3	28.92%
Div CAGR5	-13.51%
EPS Growth	8.44
EPS Growth Q	133.3
EPS Growth Quarters	2
EPS Growth Years	0
EPS Growth3 Y	57.3
EPS Growth5 Y	-7.08
FCF Growth	-60.14%
OCF Growth	-8.75%
OCF Growth Q	-11.4%
OCF Growth10 Y	12.2%
OCF Growth3 Y	28.3%
OCF Growth5 Y	14.85%
Revenue Growth	21.4x
Revenue Growth Q	13.33x
Revenue Growth Quarters	7x
Revenue Growth Years	8x
Revenue Growth3 Y	17.11x
Revenue Growth5 Y	15.17x

SHE/300558 (SHE/300558)

Coverage state: Market snapshot only — no published research

Generate the first SHE/300558 analysis

Price

Financial snapshot

Fair-value bridge

Latest news · SHE/300558

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SHE/300558 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on SHE/300558

Frequently asked questions

Metric	Value
Asset Turnover	CNY 0.38
Assets	CNY 10.7B
Cash	CNY 510.2M
Current Assets	CNY 1.7B
Current Liabilities	CNY 1.7B
Debt	CNY 2.6B
Debt EBITDA	CNY 2.12
Debt Equity	CNY 0.37
Debt FCF	CNY 25.22
Equity	CNY 6.9B
Interest Coverage	8.46
Liabilities	CNY 3.8B
Long Term Assets	CNY 9B
Long Term Liabilities	CNY 2.1B
Net Cash	CNY -2.1B
Net Cash By Market Cap	CNY -8.4
Net Debt EBITDA	CNY 1.7
Net Debt Equity	CNY 0.3
Net Debt FCF	CNY 20.19
Tangible Book Value	CNY 3.6B
Tangible Book Value Per Share	CNY 8.63
WACC	6.58

Metric	Value
Current ratio	0.99
Inventory Turnover	2.4
Net Working Capital	CNY 280.3M
Quick ratio	0.62
Working Capital	CNY -15.9M
Working Capital Turnover	CNY -9.25

Metric	Value
Buyback Yield	-0.57%
Dividend Growth	-24.6%
Dividend Growth Years	2%
Dividend per share	CNY 0.15
Dividend Years	10
Dividend Yield	0.26%
Ex Div Date	2026-06-09
Last Dividend	CNY 0.15
Payout Frequency	Annual
Payout Ratio	33.4%

Metric	Value
1Y total return	-9.21%
200-day SMA	51.36
3Y total return	2.77%
50-day SMA	57.29
50-day SMA vs 200-day SMA	50over200
5Y total return	-32.19%
All Time High	160.7
All Time High Change	-63.89%
All Time High Date	2020-07-13
All Time Low	23.19
All Time Low Change	150.19%
All Time Low Date	2016-11-07
ATR	4.5
Beta	0.51
Beta1y	0.46
Beta2y	0.42
Ch YTD	24.27
High	59.61
High52	79.8
High52 Date	2025-09-02
High52ch	-28.81%
Low	56.38
Low52	40.1
Low52 Date	2026-03-23
Low52ch	41.67%
Ma50ch	1.27%
Price vs 200-day SMA	12.98%
RSI	45.57
RSI Monthly	53.37
RSI Weekly	54.75
Sharpe ratio	0.15x
Sortino ratio	0.36
Total Return	-0.33%
Tr YTD	24.65
Tr1m	0.24%
Tr1w	-4.07%
Tr3m	17.53%

Metric	Value
Operating Income	CNY 613.2M
Operating Income Growth	6.03
Operating Income Growth Q	32.53
Operating Income Growth3 Y	67.17
Operating Income Growth5 Y	8.33
Operating margin	16.43

Metric	Value
Float	237,784,249%
Net Borrowing	206,961,290
Shares Insiders	2.34%
Shares Institutions	18.79%
Shares Out	420,733,843
Shares Qo Q	-0.17%
Shares Yo Y	0.57%

Metric	Value
Average Volume	23,506,240.25x
Bv Per Share	16.15
CAPEX	CNY -775.8M
Ch1m	0.24
Ch1w	-4.07
Ch1y	-9.49
Ch3m	17.17
Ch3y	1.67
Ch5y	-33.39
Ch6m	19.8
Change	-2.09%
Change From Open	-4.7
Close	58.02
Days Gap	2.74
Depreciation Amortization	592,878,827
Dollar Volume	128,390,600
Earnings Date	2026-08-21
EBIT	CNY 613.2M
EBITDA	CNY 1.2B
EPS	CNY 1.05
F Score	6
FCF	CNY 101.6M
FCF EV Yield	0.38x
FCF Per Share	CNY 0.24
Financing CF	81,830,129
Fiscal Year End	December
Founded	2,003
Goodwill	413,584,000
Graham Number	19.55246
Graham Upside	-66.3
Income Tax	CNY 151.8M
Investing CF	-1,087,000,842
Is Primary Listing	1
Last Earnings Date	2026-04-23
Last Report Date	2026-03-31
Lynch Fair Value	CNY 5.26
Lynch Upside	-90.93
Ma150	50.26
Ma150ch	15.43%
Ma20	63.27
Ma20ch	-8.3%
Net CF	-127,129,898
Next Earnings Date	2026-08-21
Open	59.61
P FCF Ratio	240.3
P OCF Ratio	27.82
Payment Date	2026-06-09
Position In Range	13.31
Ppne	2,926,031,959
Price Date	2026-07-30
Price EBITDA	CNY 20.24
Ptbv Ratio	6.72
Relative Volume	0.1x
Revenue	3,731,619,436x
Tax By Revenue	4.07x
Tax Rate	26.46%
Tr6m	20.17%
Volume	2,260,000
Z Score	4.61